Welcome to Knowledge Base!

KB at your finger tips

This is one stop global knowledge base where you can learn about all the products, solutions and support features.

Categories
All

Products-Benchling

Revolutionizing In Vivo Studies with Benchling In Vivo

Optimizing In Vivo Studies with Benchling

Benchling's In Vivo solution offers a cutting-edge platform designed to revolutionize in vivo studies, enabling companies to manage these studies efficiently with modern software geared towards data capture, collaboration, and insights. This innovative tool ensures that teams can save time and generate accurate in vivo study data as part of their connected R&D process. With Benchling In Vivo, researchers can accelerate study startup, capture in-life study data, and drive collaboration effectively.

Key Features of Benchling In Vivo

Benchling In Vivo provides a range of capabilities to enhance in vivo study management. From study design and review to in-life data capture, randomization, task management, and real-time data visualization, this platform offers a comprehensive set of tools to streamline the research process. Researchers can define study data structures using reusable templates, capture detailed result-level data, eliminate bias in animal selection through built-in randomization algorithms, manage tasks efficiently, and access real-time analytics for informed decision-making.

Ensuring Animal Welfare and Data Accuracy

Benchling In Vivo not only focuses on optimizing study processes but also emphasizes animal welfare and data accuracy. Researchers can monitor animal welfare through configurable alert thresholds, ensuring the timely identification of any potential issues. This proactive approach helps maintain the well-being of research subjects and the integrity of study data. By leveraging Benchling In Vivo, organizations can conduct in vivo studies with confidence, knowing that they are employing a tool that prioritizes ethical research practices and data integrity.

Testimonials and Industry Recognition

Benchling's In Vivo solution has received acclaim from industry professionals, with testimonials highlighting its efficiency and impact on research workflows. Users, such as Senior Research Associate Quinn Walker from Lyell Immunopharma, have praised the platform for its customization options and workflow improvements. Additionally, Benchling In Vivo has been trusted by over 200,000 scientists from Fortune 500 companies, startups, and academic institutions, solidifying its reputation as a leading tool in the field of in vivo research.

Learn More and Stay Updated

For organizations looking to enhance their in vivo study capabilities, Benchling In Vivo offers a wealth of resources, from product briefs to real-time data visualization features. By staying informed about the latest trends in in vivo research and leveraging modern, connected programs, companies can drive innovation and make breakthroughs in biotechnology. Benchling's commitment to providing top-tier solutions for over 1,200 biotechnology companies, from startups to Fortune 500 corporations, underscores its position as a trusted partner in the industry.


Stay Ahead in Today’s Competitive Market!
Unlock your company’s full potential with a Virtual Delivery Center (VDC). Gain specialized expertise, drive seamless operations, and scale effortlessly for long-term success.

Book A Meeting To Setup A VDCovertime

Revolutionizing Large Molecule Bioprocess Development with Benchling: A Case Study with Gilead Sciences

Introduction to Gilead Sciences and Benchling Partnership

Gilead Sciences, a renowned biopharmaceutical company dedicated to medical breakthroughs, partnered with Benchling to enhance large molecule bioprocess development. With a focus on novel therapies for life-threatening diseases, Gilead sought to bolster scientist productivity, collaboration, and data insights to elevate efficiency and predictability in their development processes.

Read article

Optimizing Agritech Research and Development with Benchling

The Importance of Agritech R&D in Revolutionizing Agriculture

Agricultural technology, or agritech, has become a key player in shaping modern farming practices. With the goal of increasing food security, reducing greenhouse gas emissions, and utilizing natural resources efficiently, agritech R&D plays a crucial role in driving innovation within the agricultural industry. To achieve these breakthroughs, research and development teams require sophisticated informatics tools that can integrate data across various domains, including chemistry, genomics, and sample tracking.

Read article

Revolutionizing Antibody and Protein R&D with Benchling Solutions

The Evolution of Antibody R&D

The field of antibodies and proteins is witnessing a transformative era in the fight against critical illnesses like cancer and immune system disorders. Innovations in monoclonal antibody technology, bispecifics, and antibody-drug conjugates are paving the way for more effective treatments with enhanced safety profiles. Antibody research and development (R&D) teams are embracing diverse formats, integrating cutting-edge technologies such as Next-Generation Sequencing (NGS) and CRISPR, and automating key processes to drive the development of groundbreaking antibodies.

Read article

ElevateBio: Revolutionizing Cell and Gene Therapy Research with Benchling's Digital Solutions

Transforming Infrastructure for Optimal CGT Development Processes

Cell and gene therapies (CGTs) are paving the way for advanced disease treatments and personalized medicines, with several already gaining FDA approval. However, one major challenge faced by CGT companies is the inefficiencies in their infrastructure, hindering the development of life-saving therapeutics. ElevateBio recognized these bottlenecks and set out to revolutionize CGT development by leveraging a groundbreaking solution. Through Benchling's integrated technologies model, ElevateBio is empowering the acceleration of design, manufacturing, and development of various genetic medicines. This unique platform offers turnkey scale and biotechnological capabilities, enabling CGT processes and programs to reach their full potential.

Read article